Paper
Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities.
Published Mar 1, 2011 · Anil Kumar, I. Ahmad, B. S. Chhikara
Bioorganic & medicinal chemistry letters
Q2 SJR score
93
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro Study
Highly CitedStudy Snapshot
3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates show potential as Src kinase inhibitors and anticancer agents against ovarian, breast, and colon cancers.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Synthesis, Src kinase inhibitory and anticancer activities of 1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols.
1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols show potential as Src kinase inhibitors and anticancer agents against human breast carcinoma cells.
2010·10citations·Deepti Sharma et al.·Biochimie
Biochimie
Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.
Conformationally constrained peptide analogues can improve the binding affinity of Src SH3 domain binding ligands, potentially generating more potent and stable analogues.
2010·10citations·R. Tiwari et al.·Biochimie
Biochimie
The Src Inhibitor AZD0530 Reversibly Inhibits the Formation and Activity of Human Osteoclasts
AZD0530 effectively inhibits human osteoclast formation and activity, potentially reducing bone degradation in diseases with enhanced osteoclast activity.
2009·60citations·T. D. de Vries et al.·Molecular Cancer Research
Molecular Cancer Research
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
SKI-606 is a promising therapeutic for breast cancer by suppressing cell motility and invasion without affecting cell proliferation or survival.
2008·152citations·A. Vultur et al.·Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
The role of Src in prostate cancer.
Src/SFK inhibition shows potential as a therapeutic strategy for prostate cancer, particularly in advanced stages, and may reduce bone metastases.
2007·194citations·K. Fizazi·Annals of oncology : official journal of the European Society for Medical Oncology
Annals of oncology : official journal of the European Society for Medical Oncology
Citations
1,2,3-Triazole Nilotinib Analogues: Synthesis and Cytotoxic Activity
Novel 1,2,3-triazole Nilotinib analogues show cytotoxic activity against various tumor cell lines, with some showing up to 85.6 % inhibition growth.
2024·0citations·Leticia Almazán-Sánchez et al.·Tetrahedron
Tetrahedron
Synthesis, design, and antiproliferative evaluation of 6-(N-Substituted-methyl)pyrazolo[3,4-d]pyrimidines as the potent anti-leukemia agents.
Compounds 17b and 19d show potential as potent anti-leukemia agents, with compound 19d showing better inhibitory activity than naphthalene derivatives and showing similar structural alignment to Methotrexate.
2024·0citations·Cheng‐Yen Chung et al.·Bioorganic chemistry
Bioorganic chemistry
One‐pot Microwave‐assisted Synthesis of Pyrazolopyrimidines from 5‐Amino‐4‐thiocyanato‐pyrazoles with Vilsmeier Reagent
Microwave-assisted synthesis of pyrazolopyrimidines and pyrazolothiazoles from 5'-amino-4-thiocyanato-pyrazoles with Vilsmeier Reagent yields pyrazolopyrimidines in good yields (61-68%)
2024·1citation·Wei-Zheng Zeng et al.·ChemistrySelect
ChemistrySelect
N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity.
N- and s-substituted pyrazolopyrimidines show promising antitumor activity against TNBC breast cancer cells, with potential for treating TNBC by inducing apoptosis and reducing tumor invasion and migration.
2024·4citations·Aeshah A Awaji et al.·Bioorganic chemistry
Bioorganic chemistry
Exploration of antiproliferative potential of modified triazole–benzohydrazone scaffold: Multitarget approach
Compound 18, a novel triazole-benzohydrazone hybrid, shows broad-spectrum antiproliferative efficacy against various cancer cells, with outstanding potency against melanoma and breast cancer cells, while being safe compared to doxorubicin.
2023·1citation·Alaa M. Ali et al.·Archiv der Pharmazie
Archiv der Pharmazie
Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties.
PP562 shows excellent anticancer potency against HGC-27 gastric cancer cells, with its inhibitory effect on proliferation likely mediated through the DDR2 target.
2023·6citations·Zukela Ruzi et al.·Bioorganic chemistry
Bioorganic chemistry
A Click Synthesis, Molecular Docking and Biological Evaluation of 1,2,3-triazoles-benzoxazepine hybrid as potential anticancer agents
Novel 1,2,3-triazole-benzoxazepine hybrid molecules show excellent anticancer properties and show potential as new inhibitory leads against the oncogenic kinase FLT3.
2022·11citations·M. Ashram et al.·Medicinal Chemistry Research
Medicinal Chemistry Research
Novel CAL-B catalyzed synthetic protocols for pyridodipyrimidines and mercapto oxadiazoles
CAL-B catalyzed novel synthetic routes enable efficient, clean, and cost-effective production of pyridodipyrimidines and mercapto oxadiazoles.
2022·2citations·A. S. Chavan et al.·Journal of Chemical Sciences
Journal of Chemical Sciences